Lob S, Pickel J, Bidlingmaier M, Schaaf L, Backmund H, Gerlinghoff M, Stalla G K
Max-Planck-Institute of Psychiatry, Munich, Germany.
Exp Clin Endocrinol Diabetes. 2003 Aug;111(5):278-82. doi: 10.1055/s-2003-41286.
Circulating concentrations of leptin are exceedingly low in severe malnutrition as seen in the acute state of anorexia nervosa (AN). During refeeding therapy plasma leptin levels increase to normal and in some cases peak at values in excess of the BMI of matched controls even before a normal body weight has been achieved. Peak leptin levels are possibly the cause of an increased energy expenditure during this stage of the disorder and might predispose to renewed weight loss (rebound phenomenon). In this study we investigated the role of leptin fluctuations as a prognostic factor of therapeutic success in AN. In 11 anorectic female patients serum leptin levels, BMI and body fat percentage were evaluated in four-week intervals during a conventional refeeding program over three months (group 1). The results of the first two measurements were used to determine a range of increases in leptin levels in relation to increases in BMI. The values between the 25th and 75th percentiles determined the reference range. In a second group of 9 anorectic female patients serum leptin levels, BMI, body fat percentage and the increase in the leptin level in relation to the BMI of each subject were investigated for three months every two weeks. These patients were also treated according to the same conventional refeeding program, but the caloric intake was reduced or increased (+/-250 kcal/d) if the increase in the leptin level, in relation to the increase in the BMI, had exceeded or fallen short of the reference range. During the refeeding therapy every subject of each group experienced increases in serum leptin levels, BMI and body fat percentage. Six subjects of group 1 and six subjects of the second group had an increase in leptin levels in relation to the increase of the BMI out of the reference range at least once. To investigate the therapeutic outcome of leptin monitoring and the following alteration of caloric intake, weight gain of the patients of both groups during the whole treatment was compared. No significant difference was found. Our results probably do not support the findings that high leptin levels predispose to a renewed loss of weight. The outcome in our patients whose caloric intake was modified due to their serum leptin levels was not significantly improved.
在神经性厌食症(AN)急性期所见的严重营养不良状态下,循环中瘦素的浓度极低。在重新喂养治疗期间,血浆瘦素水平会升至正常,在某些情况下,甚至在体重尚未恢复正常之前,其峰值就会超过匹配对照组的体重指数(BMI)。瘦素水平峰值可能是该疾病此阶段能量消耗增加的原因,并且可能易导致体重再次下降(反弹现象)。在本研究中,我们调查了瘦素波动作为神经性厌食症治疗成功的预后因素的作用。在11名厌食女性患者中,在为期三个月的常规重新喂养计划期间,每四周评估一次血清瘦素水平、BMI和体脂百分比(第1组)。前两次测量的结果用于确定瘦素水平相对于BMI增加的升高范围。第25至75百分位数之间的值确定参考范围。在另一组9名厌食女性患者中,每两周对血清瘦素水平、BMI、体脂百分比以及瘦素水平相对于每个受试者BMI的增加情况进行三个月的调查。这些患者也按照相同的常规重新喂养计划进行治疗,但如果瘦素水平相对于BMI的增加超过或未达到参考范围,则热量摄入会减少或增加(±250千卡/天)。在重新喂养治疗期间,每组的每个受试者血清瘦素水平、BMI和体脂百分比均有所增加。第1组的6名受试者和第二组的6名受试者至少有一次瘦素水平相对于BMI的增加超出参考范围。为了研究瘦素监测及随后热量摄入改变的治疗效果,比较了两组患者在整个治疗期间的体重增加情况。未发现显著差异。我们的结果可能不支持高瘦素水平易导致体重再次减轻这一观点。因血清瘦素水平而调整热量摄入的患者的治疗结果并未得到显著改善。